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We previously proposed that the conservation of the nonessential syncytium-inducing phenotype among all reported avian
reovirus (ARV) isolates may reflect a mechanism for enhanced virus dissemination in vivo, which in turn could contribute to
the natural pathogenicity of ARV. Direct testing of this hypothesis has been hampered by the lack of available virus strains
with defined differences in their fusion-inducing capability. We now report on the characterization of two ARV strains, ARV-176
and ARV-138, that exhibited strain-specific differences in their fusogenic properties, which correlated with their pathogenic
potential in embryonated eggs. Moreover, both virus strains possessed similar replicative abilities in cell culture, suggesting
that the weakly fusogenic ARV-138 virus is specifically inhibited in its syncytium-inducing ability. To test the use of these
viruses for reassortant studies aimed at assessing the role of cell fusion in viral pathogenesis, a preliminary genetic analysis
was undertaken using a monoreassortant that contained nine genome segments from the parental ARV-138 virus and the S1
genome segment from the highly fusogenic and pathogenic ARV-176 parental virus. The monoreassortant possessed the full
fusogenic potential of the ARV-176 parental virus and displayed enhanced embryo pathogenicity, providing the first genetic
evidence implicating the ARV S1 genome segment in both syncytium formation and viral pathogenesis. © 1998 Academic Press
INTRODUCTION
The avian reoviruses (ARVs) represent a distinct spe-
cies in the genus Orthoreovirus, family Reoviridae (Nibert
et al., 1996). ARVs are distinguished from the prototype
mammalian reoviruses on the basis of their natural
pathogenicity in their animal host and by their unusual
propensity for inducing cell–cell fusion from within, re-
sulting in extensive syncytium formation in infected cells
(Kawamura et al., 1965; Ni and Ramig, 1993; Robertson
and Wilcox, 1986; Van der Heide, 1977). Syncytium for-
mation has also been detected in the tissues of infected
animals (Kibenge et al., 1985), suggesting that cell fusion
could be a contributing factor to viral pathogenesis. Al-
though all characterized ARV isolates induce syncytium
formation, the role of syncytium formation in the ARV
replication cycle and in viral pathogenesis has not been
defined.
Abrogation of ARV-induced cell fusion by the vesicle
transport inhibitor brefeldin A demonstrated that the
mechanism responsible for syncytium formation is non-
essential for virus replication in cell culture (Duncan et
al., 1996). Apparently, the ARV fusogenic phenotype does
not represent the sequelae of an essential step in the
ARV replication cycle. This is contrary to syncytium for-
mation induced by enveloped viruses, which target their
fusion proteins to the cell membrane as an essential
step in the assembly and release of infectious virions
(Petterson, 1991; Stephens and Compans, 1988). Al-
though ARV-induced cell fusion was not required for
virus release or virus-induced cell killing, it did signifi-
cantly increase the rate of both of these processes.
These observations lead us to hypothesize that the con-
servation of the syncytium-inducing capability of ARVs
may reflect a competitive advantage conferred on the
virus by a mechanism that facilitates rapid dissemination
of the infection within an infected animal (Duncan et al.,
1996). Such a process for enhanced virus spread could
conceivably contribute to the natural pathogenic poten-
tial of this group of nonenveloped viruses. A similar
correlation between cell fusion induced by some envel-
oped viruses and viral pathogenesis has also been pro-
posed (Goodman and Engel, 1991; Koot et al., 1993; Park
et al., 1994), although the involvement of syncytium for-
mation in pathogenicity remains uncertain (Cloyd and
Moore, 1990; Groenink et al., 1993; Yu et al., 1994)
An improved understanding of the relationship among
ARV-induced cell fusion, virus replication, and viral
pathogenesis would be facilitated by the analysis of
different virus strains that exhibit distinct syncytium-in-
ducing and pathogenic properties. Such virus strains can
be used to generate genetic reassortants, a procedure
extensively applied by the late Bernard Fields and co-
workers to identify mammalian reovirus genome seg-
ments involved in viral pathogenesis and in numerous
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aspects of virus replication (e.g., Hazelton and Coombs,
1995; Hooper and Fields, 1996; Yin et al., 1996). Although
several ARV strains with distinct pathogenic properties
have been described (Clark et al., 1990; Hieronymous et
al., 1983; Tang et al., 1987), there are no reports describ-
ing strain-specific differences in the fusion-inducing po-
tential of different ARV isolates. The absence of a char-
acterized ARV strain with a definable defect in its syncy-
tium-inducing capability has prevented the use of
reassortment analysis to define the relationship between
virus-induced cell fusion and pathogenesis.
We now report on the characterization of two ARV
strains with distinct fusion-inducing and pathogenic
properties. Most notably, the fusogenic and patho-
genic potential of the viruses was unrelated to their
replicative abilities in cell culture, suggesting that the
reduced fusogenic ability of the ARV-138 strain is not
the consequence of ineffective virus infection or rep-
lication. A preliminary genetic reassortment analysis
using these two virus strains implicated the S1 ge-
nome segment in both virus-induced cell fusion and
viral pathogenesis.
RESULTS
ARV strains 176 and 138 exhibit distinct syncytium-
inducing properties
Although no strain of ARV defective for syncytium for-
mation has been described, we observed that a partic-
ular strain of ARV under investigation in our laboratory,
ARV-138, was inefficient at inducing cell fusion. Infection
of a quail cell line, QM5, with ARV-176 or ARV-138 at a
low multiplicity of infection (m.o.i.) resulted in foci of
infection detectable by immunostaining using ARV-spe-
cific antiserum (Figs. 1A and 1B). Although both strains
induced the formation of multinucleated syncytia, ARV-
138 induced syncytial foci that were considerably smaller
than those associated with ARV-176 infection under iden-
tical experimental conditions. Infected cell monolayers
stained with a water-soluble Wright–Giemsa stain clearly
demonstrated the polykaryon nature of these infected-
cell foci and the reduced fusogenic potential of ARV-138
(Figs. 1C and 1D).
The kinetics of syncytium formation induced by these
two ARV strains was quantified by determining the aver-
FIG. 1. Isolation of an ARV strain with reduced fusogenic potential. Monolayers of quail cell fibroblasts (QM5 cells) were infected at an m.o.i. of 0.03
with ARV-176 (A and C) or ARV-138 (B and D). Infected monolayers were incubated for 16 h before staining with a reovirus-specific rabbit polyclonal
antiserum and goat anti-rabbit IgG conjugated with alkaline phosphatase to detect viral antigens (A and B) or with a water-soluble Wright–Giemsa
stain (Diff-Quik) to reveal cell nuclei (C and D).
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age number of nuclei per syncytium at various times
postinfection (p.i.) (Fig. 2). ARV-176 induced small syncy-
tial foci of infection within 12 h after infection of QM5
cells at a low m.o.i. These syncytial foci rapidly increased
in size to an average of 25–30 nuclei per syncytium by
16 h p.i. and to .50 nuclei per syncytium by 22 h p.i. (Fig.
2). Conversely, ARV-138 syncytia were difficult to detect
at 12 h p.i. and did not become apparent until 14–16 h p.i..
By 20–22 h p.i., syncytia induced by ARV-138 had in-
creased in size to an average of only ;20 nuclei per
syncytium, 2.5- to 3-fold smaller than those induced by
ARV-176. In repeated experiments, the difference be-
tween the ARV-138 and ARV-176 syncytial indices ranged
from 2.3- to 3.2-fold. This represents the first identifica-
tion of an ARV with a quantifiable difference in its fusion-
inducing capability.
The weakly fusogenic ARV-138 strain displays limited
embryo pathogenicity
We previously hypothesized that the syncytium-induc-
ing property of ARV may contribute to viral pathogenesis
(Duncan et al., 1996). The identification of two strains of
ARV with distinct fusogenic properties allowed us to test
this hypothesis by determining whether there was a
correlation between the syncytium-inducing and patho-
genic potential of the viruses. ARV-176 has been de-
scribed as a highly pathogenic isolate that induces rapid
morbidity or mortality in the majority of test animals
infected with this virus (Hieronymus et al., 1983; Tang et
al., 1987). ARV-138 has not been as extensively charac-
terized, but in a separate report, it was shown to induce
no mortality in test animals and exhibited limited ability
to induce morbidity (Drastini et al., 1994). We undertook a
direct comparison of the pathogenic potential of these
two virus strains by using embryonated eggs, a more
convenient assay than whole animal studies. Both virus
strains were used to inoculate 10-day-old chicken em-
bryos in the chorioallantoic cavity, and embryo mortality
was monitored over time (Fig. 3). In all experiments,
ARV-176 induced 80–100% mortality by 4–5 days p.i. at a
time when embryo mortality induced by ARV-138 was
,10% (see also Fig. 8). Equivalent numbers of mock-
infected embryos showed ,10% mortality (data not
shown), similar to the situation with embryos infected
with ARV-138. These results demonstrated that the di-
verse pathogenic properties of the two virus strains ob-
served in vivo are reproducible in ovo. Furthermore, al-
though the data do not establish a causal link between
ARV-induced cell fusion and pathogenesis, the results
did provide the first evidence of a correlation between
the strain-specific fusogenic and pathogenic properties
of ARV.
Strain-specific differences in cell fusion and
pathogenicity are unrelated to the relative replicative
ability of the virus
ARV strains with distinct fusogenic and pathogenic
properties may be used for reassortant analysis to eval-
uate whether any correlation exists between syncytium
formation and virus pathogenesis. Such a genetic ap-
proach would be facilitated by using a parental virus
strain that is specifically altered in its fusion-inducing
potential. It was necessary, therefore, to determine
whether the decreased fusogenic and pathogenic poten-
tial of ARV-138 reflected either an overall decrease in the
replication properties of this virus strain or a specific
defect in the mechanism responsible for cell fusion. To
address this issue, we compared several aspects of the
virus replication cycle in cell culture.
The cell-binding and internalization capabilities of
FIG. 2. Quantitative analysis of strain-specific ARV-induced syncy-
tium formation. Duplicate quail cell monolayers were infected with
ARV-176 or ARV-138 as described in Fig. 1 and stained with Diff-Quik at
various hours p.i. The average number of nuclei contained per syncy-
tium was determined by counting the nuclei per syncytium in five
random fields. Results are the mean 6 SEM of four separate experi-
ments.
FIG. 3. ARV-176 and ARV-138 exhibit distinct embryo pathogenicities.
Ten-day-old chicken embryos were inoculated into the chorioallantoic
cavity with 1 3 103 pfu of ARV-176 or ARV-138, with 10 embryos for each
strain of virus. Infected embryos were observed daily for embryo
mortality as determined by the lack of embryo movement and the
appearance of blackened blood vessels indicative of necrosis. Re-
ported results are the mean 6 SEM of three separate experiments.
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each virus strain were assessed using equivalent num-
bers of radiolabeled virus particles with comparable spe-
cific activities. Bound virus particles were detected by
SDS–PAGE and autoradiography (Fig. 4A, 0 time points).
Quantitative analysis of the density contained in the
major m and s capsid proteins detected in scans of the
autoradiographs indicated that both viruses possess
similar steady-state cell-binding efficiencies under the
experimental conditions used in this assay. These re-
sults suggested that the receptor-binding function of the
s3 protein (Shapouri et al., 1996) was not impaired in the
weakly fusogenic ARV-138 virus. More importantly, the
kinetic analysis of virus entry, as determined by the
appearance of the d polypeptide, an entry-specific cleav-
age product of the major m2C outer capsid protein (Dun-
can, 1996; Sturzenbecker et al., 1987), also revealed no
obvious difference between the two viruses in the early
events after virus–cell interaction (Fig. 4A, 15–60 min
time points). The appearance of the ARV-specific d9
polypeptide, an alternate cleavage product of m2C, was
delayed with both of these virus strains relative to the
previously characterized strain S1133 virus (see Duncan,
1996). The entry results suggested that the two viruses
were equally capable of infecting cultured cells, which
was confirmed using a quantitative focus-forming assay
(data not shown), similar to the results presented in Figs.
1A and 1B. The cumulative weight of the attachment and
entry results implied that the decreased pathogenic and
fusogenic potential of ARV-138 is unlikely to be the result
of a diminished capacity to bind or infect cells.
Similarly, an analysis of virus macromolecular synthe-
sis indicated that ARV-138 is not impaired in its ability to
direct the synthesis of viral proteins. As shown in Fig. 4B,
both ARV strains displayed a similar pattern of viral
protein synthesis in infected QM5 monolayers. This was
most evident by observing the appearance of the s-class
proteins that were detectable in cells infected with either
virus strain by 8 h p.i.. The rate of viral protein synthesis
for both viruses increased to a maximum by 12 h p.i. and
decreased thereafter, along with host translation levels,
due to virus-induced cytopathic effects (Duncan et al.,
1996). In addition, immunoprecipitation of infected cell
extracts indicated that both strains synthesized a similar
complement of viral proteins (Fig. 4C). Therefore, the
reduced fusogenic and pathogenic potential of ARV-138
does not appear to be the consequence of a generalized
defect in virus macromolecular synthesis.
The reduced pathogenic potential of ARV-138 could
not be accounted for by a deficiency in the production of
progeny virions. The rate and extent of infectious ARV-
138 progeny virus production were not reduced relative
to titers obtained after ARV-176 infection (Fig. 5); in actu-
ality, the final yield from cultures infected by ARV-138 was
reproducible 3- to 5-fold higher than corresponding cul-
tures infected by ARV-176. The above analyses indicated
that the distinct syncytium-inducing properties and
pathogenicities of these two ARV strains appear to be
unrelated to any of the processes that govern the virus
replication cycle at a cellular level and suggested that
FIG. 4. The extent of syncytium formation and viral pathogenesis is unrelated to virus macromolecular synthesis or cell infection. (A) Radiolabeled,
purified virus particles of ARV-176 and ARV-138 were adsorbed to quail cell monolayers at room temperature, followed by extensive washing to remove
unadsorbed particles. Cultures were shifted to 37°C to permit virus entry, and at various times after the temperature shift (0, 15, 30, or 60 min), cells
were harvested, the lysates were fractionated by SDS–PAGE, and radiolabeled viral proteins were detected by autoradiography. The locations of the
major l, m, and s viral structural proteins are indicated along with the location of the entry-specific d polypeptide, a cleavage product of the m2C outer
capsid protein. (B) Quail cell monolayers were infected with either strain of ARV at an m.o.i. of 10, and at the indicated times (8, 12, or 16 h p.i.),
monolayers were pulse-labeled for 30 min with [35S]methionine, harvested in detergent lysis buffer, fractionated by SDS–PAGE, and radiolabeled
translation products were detected by autoradiography. The locations of the major l, m, and s virus proteins are indicated. U indicates uninfected
cell lysate. (C) Radiolabeled viral proteins present in the 16-h time points from panel B were detected by immunoprecipitation using reovirus-specific
antiserum. The immunoprecipitates were analyzed by SDS–PAGE and autoradiography. The locations of the major l, m, and s virus proteins are
indicated.
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ARV-138 is specifically impaired in its syncytium-induc-
ing ability.
The ARV-176 S1 genome segment is implicated in
efficient cell fusion and enhanced embryo
pathogenicity
The apparently specific nature of the fusogenic defect
in ARV-138 suggested that this virus strain may represent
a useful parental virus for the genetic investigation of the
relationship between cell fusion and pathogenesis and
to identify viral gene products that influence these prop-
erties. To test the use of these two viruses in reassortant
studies, we isolated a small panel of reassortants among
the progeny generated after coinfection of quail cells
with ARV-176 and ARV-138. In a first screen of the prog-
eny produced from such a coinfection, we identified six
reassortants, including a monoreassortant containing
nine genome segments from ARV-138 and the S1 ge-
nome segment from ARV-176 (Fig. 6). Because the s3
protein of ARV is a product of the S1 genome segment
(Schnitzer, 1985; Varella and Benavente, 1994) and has
been implicated in syncytium formation (Theophilos et
al., 1995), we tested this monoreassortant for its syncy-
tium-inducing and pathogenic capability.
The syncytium-inducing ability of the S1 monoreassor-
tant was compared with that of the two parental viruses
and an L2/3 reassortant, one of only two reassortants
isolated that did not contain the ARV-176 genome seg-
ment, using the quantitative syncytium-forming assay
(Fig. 7). The S1 monoreassortant possessed the com-
plete fusogenic ability of the ARV-176 parental virus-
generating syncytial indices that ranged from 2.1- to
3.2-fold greater than those induced by ARV-138 or the
L2/3 reassortant. Moreover, both reassortants exhibited
replicative abilities similar to that of the ARV-138 parental
virus (data not shown) indicating that syncytium forma-
tion was not influenced by altered virus replication. The
clear segregation of the ARV-176 syncytial phenotype
with the S1 genome segment suggested a direct involve-
ment of S1-encoded gene product or products in ARV-
induced cell fusion and supported the proposal that
ARV-138 is specifically impaired in its fusion-inducing
ability.
FIG. 5. Strain-specific differences in ARV pathogenicity do not reflect
differences in the replicative ability of the virus. Duplicate monolayers
of quail cells were infected with ARV-176 or ARV-138 at an m.o.i. of 10,
and at various times p.i., the monolayers were harvested, and the yield
of infectious progeny virions was determined by plaque assay on QM5
cell monolayers. Results are the average of two separate experiments.
FIG. 6. Isolation of an S1 genome segment monoreassortant. Reas-
sortants were isolated among the progeny obtained after coinfection of
quail cells with the parental ARV-176 and ARV-138 viruses. Genomic
dsRNA was isolated from a plaque-purified S1 genome segment
monoreassortant (S1) and from a reassortant containing the strain
176-L2 and -L3 genome segments (L2/3). The genome segments of the
parental viruses and the reassortants were resolved by SDS–PAGE and
detected by silver staining. A 10% polyacrylamide gel was used to
resolve the L, M, and S1 genome segments (top two panels), whereas
the remaining S genome segments were resolved on a 7% polyacryl-
amide gel (bottom panel). The identities of the various genome seg-
ments are indicated on the left.
FIG. 7. The ARV-176 S1 genome segment is responsible for extensive
syncytium formation. The parental viruses (ARV-176 and ARV-138) and
the two reassortants (176-S1 and 176-L2/3) were used to infect quail
cell monolayers at an m.o.i. of 0.03, and the syncytial index for each
virus was determined as outlined in Fig. 2. Results are the mean 6
SEM from three separate experiments.
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As a first step toward assessing the influence of the
fusion-inducing S1 genome segment on virus pathogen-
esis, the pathogenic potential of the two parental viruses
was compared with that of the S1 monoreassortant in
embryonated eggs (Fig. 8). As previously described (Fig.
3), ARV-138 induced no embryo mortality by 5 days p.i.
versus the 100% mortality induced by ARV-176. In two
separate experiments, the monoreassortant exhibited an
intermediate pathogenic potential, inducing mortality in
60% of the embryos by 5 days p.i. (Fig. 8). These results,
although preliminary, did provide the first genetic evi-
dence of the involvement of the ARV S1 genome segment
in viral pathogenesis. In addition, the data suggested
that although syncytium formation may be primarily, if not
exclusively, influenced by the S1 genome segment, ARV
pathogenesis appears to reflect a multigenic phenome-
non.
DISCUSSION
Characterization of an ARV with reduced fusogenic
and pathogenic potential
Although distinct pathogenicities have been described
for numerous ARV isolates (e.g., Clark et al., 1990; Hiero-
nymous et al., 1983; Tang et al., 1987), this represents the
first report of a quantifiable difference in the syncytium-
inducing ability of different ARV strains. Although ARV-
138 is not a syncytium-negative virus strain, it is clearly
impaired in its syncytium-inducing ability in fibroblasts
(Figs. 1 and 2). In addition, ARV-138 was significantly
reduced in its pathogenic potential in embryonated eggs
compared with the highly fusogenic ARV-176 strain (Figs.
3 and 8), pathogenic phenotypes that mimic those in-
duced in infected birds (Clark et al., 1990; Drastini et al.,
1994; Hieronymous et al., 1983; Tang et al., 1987).
Similar to these results, Takase et al. (1987) reported a
strong correlation in strain-specific differences between
ARV pathogenesis in whole animals versus embryonated
eggs. Moreover, the degree of virus pathogenesis corre-
lated with the extent of cytopathic effect induced in cell
cultures after the first passage of clinical isolates, al-
though no attempt was made to describe the extent of
cell fusion (Takase et al., 1987). Our characterization of
an ARV with impaired fusogenic and pathogenic poten-
tial and the preliminary genetic analysis of this virus
represent the first demonstrated correlation between the
conserved fusogenic potential of ARVs and their natural
pathogenicity. Establishing the significance of this corre-
lation will require a comparative analysis of the rate and
extent of virus dissemination and histopathology induced
in infected animals by these two parental viruses and a
comprehensive group of reassortants.
Equally important was our demonstration that the re-
duced pathogenic and fusogenic potential of ARV-138
was unrelated to the replicative abilities of the virus in
cell culture (Figs. 3–5). The current data suggest that
ARV-138 is specifically defective in the mechanisms re-
sponsible for cell fusion that are not the result of general
deficiencies in other aspects of the virus replication
cycle at a cellular level. These results corroborated our
previous studies demonstrating that the processes gov-
erning cell fusion are unrelated to other aspects of the
virus replication cycle (Duncan et al., 1996). Conse-
quently, the genetic identification of genome segments
involved in syncytium formation and viral pathogenesis
using these two parental viruses is unlikely to be com-
plicated by viral gene products that merely influence
virus replication.
Role of the S1 genome segment in syncytium
formation
Previous reports have suggested the possible involve-
ment of either the major outer capsid proteins, m2C
and/or s2, or the cell attachment protein, s3, in ARV-
induced syncytium formation (Ni and Ramig, 1993;
Theophilos et al., 1995). Our current quantitative analysis
of cell fusion induced by the parental viruses and the two
reassortants implicated the S1 genome segment in ARV-
induced cell fusion; although based solely on the
monoreassortant data, this assignment must still be
viewed as tentative. For instance, it has been demon-
strated that specific mutations in certain genome seg-
ments of mammalian reovirus may be required to gen-
erate “acceptance signals” that permit virus particles to
package heterologous genome segments (Roner et al.,
1995). Consequently, alterations in the coding sequence
of other genome segments in the S1 monoreassortant
that influence syncytium formation cannot be excluded.
This scenario, however, seems unlikely because it re-
quires that a mutation in an ARV-138 genome segment
FIG. 8. The S1 genome segment significantly influences ARV patho-
genesis. The parental viruses (ARV-176 and ARV-138) and the S1
monoreassortant (176-S1) were used to infect embyonated eggs as
outlined in Fig. 3 (10 embryos per treatment). Infected embryos was
observed daily, and the percent mortality was determined. Results are
the average of two separate experiments.
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that is required for “acceptance” of the ARV-176 S1 ge-
nome segment happens, coincidentally, to confer the full
fusogenic potential of ARV-176 on the monoreassortant.
In addition, one of only two reassortants isolated that
contained the ARV-138 S1 genome segment behaved
identically to the parental ARV-138 virus in fusion assays
(Fig. 7), which is in accord with our prediction that the
ARV-176 S1 genome segment is required for enhanced
syncytium formation. These results suggest that muta-
tions in other genome segments that are required to
permit the formation of reassortants are unlikely to con-
tribute to enhanced syncytium formation.
The genetic analysis implicating the ARV S1 genome
segment in cell fusion has recently been confirmed using
transfection assays. Our analysis indicates that a pre-
dicted small open reading frame encoding a 10kDa pro-
tein previously detected in the sequence of the ARV-
S1133 S1 genome segment (Shapouri et al., 1995) is both
necessary and sufficient for virus-induced cell fusion
(Shmulevitz and Duncan, unpublished observations).
Therefore, the results obtained from both genetic and
molecular analyses indicate the direct involvement of the
S1 genome segment in virus-induced cell fusion.
Neither of these experimental approaches, however,
eliminates a potential role for other genome segments in
virus-induced cell fusion. In the case of the genetic
analysis, the phenotype of genetic reassortants can be
influenced by the nature of the recipient genetic back-
ground (Chen et al., 1989), which can complicate assign-
ment of particular phenotypes to specific genome seg-
ments. Further characterization of an extended group of
reassortants is required to determine the role, if any, of
other genome segments in influencing the extent of ARV-
induced cell fusion.
Role of the S1 genome segment in viral pathogenesis
Our initial genetic survey provided the first evidence
implicating the ARV S1 genome segment in virus patho-
genesis. The data also suggested that the S1 genome is
not solely responsible for the pathogenicity of ARV-176
(Fig. 8), indicating, not surprisingly, that ARV pathogene-
sis is influenced by several genome segments. The pre-
liminary genetic analysis demonstrated the use of these
two ARV strains in investigating the viral factors influenc-
ing virulence and the relationship between ARV-induced
cell fusion and pathogenicity. Clearly, a larger panel of
reassortants is required to confirm the direct involvement
of the S1 genome segment in ARV pathogenesis and to
identify additional virulence determinants.
The implication of the ARV S1 genome segment in viral
pathogenesis is similar to the situation with mammalian
reovirus. The role of the mammalian reovirus S1 genome
appears to reflect primarily the involvement of the en-
coded s1 protein in receptor attachment (Kauffman et al.,
1983; Lee et al., 1981; Tyler et al., 1986; Weiner et al., 1977,
1978; Wilson et al., 1994). Even though the ARV S1 ge-
nome segment encodes the viral cell attachment protein
s3 (Shapouri et al., 1996), the ARV-138 s3 protein does
not appear to adversely influence steady-state receptor
interactions or, more importantly, the efficiency of virus
infection of cultured cells (Fig. 4A). This observation
suggests that receptor interactions alone may not be
responsible for the enhanced pathogenic potential con-
tributed by the ARV-176 S1 genome segment. Confirma-
tion of this conjecture requires more extensive receptor-
binding studies performed on primary cell cultures ob-
tained from any tissues that display strain-specific
alterations in virus infection or replication after infection
in whole animals.
The segregation of both enhanced fusogenic and
pathogenic properties with the S1 genome segment, in a
replication-independent manner, offers an alternative hy-
pothesis to explain the role of the S1 genome segment in
ARV pathogenesis. The impaired fusogenic ability of
ARV-138 in cell culture suggests that a similar situation
occurring in vivo could reduce the rate of virus dissem-
ination and the extent of tissue destruction within an
infected animal contributing to the reduced pathogenic
potential of this virus strain. Several additional lines of
evidence support this hypothesis. First, the observation
that ARV-induced cell fusion is not restricted to cells in
culture but also occurs in the tissues of infected animals
(Kibenge et al., 1985) suggests that cell fusion may affect
virus–host interactions in situ, although the extent of cell
fusion in vivo has never been rigorously examined. Sec-
ond, although syncytium formation is not essential for
virus release or virus-induced cytopathology, it does en-
hance the rate of both of these processes by accelerat-
ing a lytic-type infection that contributes to the progres-
sion of the infection in cell culture (Duncan et al., 1996).
Third, we previously demonstrated that the mechanisms
responsible for syncytium formation are distinct from
those involved in virus replication in cell culture (Duncan
et al., 1996), consistent with our present results indicat-
ing the more robust replicative ability of the weakly
fusogenic ARV-138 virus (Fig. 4). Therefore, syncytium
formation, or the lack thereof, may influence virus dis-
semination independent of virus replication at a cellular
level.
A similar correlation between syncytium formation and
viral pathogenesis has been observed with several en-
veloped viruses. For example, a herpes simplex virus
type 1 variant capable of extensive syncytium formation
exhibits significantly increased pathogenic potential in
vivo (Goodman and Engel, 1991). The syncytial and
pathogenic phenotypes were mapped to a single region
near the carboxyl terminus of glycoprotein B, and most
importantly, this alteration did not affect viral replication,
suggesting a correlation between syncytium formation
and pathogenesis (Engel et al., 1993). Similarly, the ap-
pearance of syncytium-inducing strains of HIV-1 corre-
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lates with an unfavorable prognosis (Bozzette et al., 1993;
Groenink et al., 1993; Koot et al., 1993).
The current analysis of ARV has provided the first
genetic evidence implicating the S1 genome segment in
both syncytium formation and pathogenesis. A more de-
tailed kinetic analysis of ARV pathogenesis in vivo using
the two ARV strains characterized in this report and
including an expanded group of reassortants should
contribute to an improved understanding of the relation-
ship between the unusual syncytium-inducing ability of
this group of nonenveloped viruses and their pathogenic
potential.
MATERIALS AND METHODS
Virus strains and cells
ARV-176 has been previously described (Duncan et al.,
1996). Strain SK138a (ARV-138) was originally isolated in
chicken embryos inoculated with the extract from the
hock joint of an infected chicken in New Brunswick
(Canada). We obtained ARV-138 from Frederick Kibenge
(Atlantic Veterinary College, University of Prince Edward
Island) after six low-multiplicity passes in Vero cells
(Drastini et al., 1992). Both strains were plaque purified
and amplified to pass four using an m.o.i. of 0.01 in a
continuous quail cell line, QM5, a clonal derivative of
QT6 cells that exhibits a very low spontaneous fusion
index (Antin and Ordahl, 1991). QM5 cells were grown in
Medium 199 supplemented with 10% tryptose phosphate
broth, 10% fetal bovine serum, and penicillin–streptomy-
cin (50 U/ml and 50 mg/ml, respectively).
Staining cell monolayers and determination of a
syncytial index
To quantify the relative extent of virus-induced syncy-
tium formation, a syncytial index was calculated as pre-
viously described (Duncan et al., 1996). Monolayers of
QM5 cells were infected with the various virus isolates at
an m.o.i. of 0.03 (to generate foci of infection) and incu-
bated for varying lengths of time. At the indicated times
p.i., medium was removed from duplicate wells, and the
cells were washed once with PBS, fixed with methanol
and stained using a water-soluble Wright–Giemsa stain
(Diff-Quik) according to the manufacturer’s protocol (VWR
Scientific). The average number of nuclei per syncytium
was determined by counting five random fields from
duplicate samples at 1003 magnification using bright-
field microscopy. The number of nuclei contained in a
minimum of 30 syncytia were counted to determine the
average number of nuclei per syncytium.
A similar procedure was used in a focus-forming as-
say to detect viral foci of infection, except that after
fixation, monolayers were stained using polyclonal rabbit
antiserum raised against virus structural proteins as pre-
viously described (Duncan et al., 1996). Foci were de-
tected using a secondary goat anti-rabbit IgG conjugated
with alkaline phosphatase (Life Technologies) according
to standard protocols (Harlow and Lane, 1988).
Embryo pathogenesis analysis
Fertilized eggs were obtained from a specific patho-
gen-free flock screened for ARV and maintained at the
Agriculture Canada Research Center (Ottawa). The eggs
were incubated at 37°C in a moist environment and
allowed to develop to 10 days postfertilization. The em-
bryos were checked for viability and stage of develop-
ment by candling, and the locations of the embryo and
air sac were marked. The titrated virus stocks were
diluted to 1 3 103 pfu/0.1 ml in tissue culture medium
(minus fetal bovine serum) and inoculated into the cho-
rioallantoic cavity using a 23-gauge needle. Control sam-
ples were inoculated with 0.1 ml of dilution medium. The
puncture holes were sealed with vacuum grease, and
the embryonated eggs were returned to the incubator.
Eggs were candled daily and scored for embryo viability
by a lack of embryo movement and darkened blood
vessels indicative of necrosis.
Viral protein synthesis and immunoprecipitation
The kinetics and extent of viral protein synthesis were
analyzed in infected QM5 cells (m.o.i. of 10) by [35S]me-
thionine pulse-labeling and SDS–PAGE as previously de-
scribed (Duncan et al., 1996). Infected and uninfected,
radiolabeled cell extracts were immunoprecipitated us-
ing a combination of a rabbit antiserum prepared against
purified ARV as previously described (Duncan, 1996;
Duncan et al., 1995) and a chicken antiserum obtained
after virus infection. The chicken antiserum recognizes
virus nonstructural proteins in addition to the structural
proteins recognized by the rabbit antiserum. Both anti-
sera (1:400 dilution) were incubated with detergent-dis-
rupted cell lysates for 60 min at room temperature, fol-
lowed by the addition of rabbit anti-chicken Ig (DAKO)
and an additional 60-min room temperature incubation.
Immune complexes were precipitated using IgGsorb
(The Enzyme Center) and released by boiling in SDS
protein sample buffer (Laemmli, 1970) before SDS–PAGE.
Radiolabeled virus purification and cell binding
assays
[35S]Methionine-labeled virus particles were purified
by CsCl gradient centrifugation and used to assess the
efficiency of virus attachment to, and entry into, quail
cells as previously described (Duncan, 1996). Monolay-
ers of cells in 12-well cluster plates (1 3 106 cells/well)
were infected at room temperature using ;100,000 cpm
(1010 virus particles). Assuming ;105 receptors per cell
(Armstrong et al., 1984; Tardieu et al., 1982), the number
of virus particles per well was well below the concen-
tration required to saturate the cell receptors. After ab-
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sorption and washing, cultures were incubated at 37°C
for various times before harvesting. The extent of virus
attachment and entry was assessed by SDS–PAGE and
autoradiography followed by quantification of the inten-
sity of virus bands on the scanned x-ray film. The specific
activity of both virus strains was 80,000–170,000 cpm/
1010 particles and both viruses displayed similar particle-
to-pfu ratios in quail cells as determined by plaque as-
says.
Virus growth curves
The rate and extent of ARV replication in QM5 cells
were determined by infecting cells at an m.o.i. of 10 for
1 h at 37°C. After absorption, the inoculum was removed,
and the monolayers were washed three times with warm
PBS and overlaid with warm Medium 199 containing 1%
fetal bovine serum. At various times p.i., the cells from
duplicate wells were scraped into the culture medium,
harvested, and disrupted by three freeze–thaw cycles.
The total infectious progeny virus titer was determined
by plaque assay on QM5 cells as previously described
(Duncan et al., 1996).
RNA analysis
Viral dsRNA genome segments were isolated from
concentrated virus stocks. The concentrated virus was
resuspended in TMN (10 mM Tris, pH 8.0, 10 mM MgCl2,
150 mM NaCl) and treated with 10 mg/ml RNase A and
DNase to remove contaminating extra-virion nucleic
acid, and the virus particles were disrupted with 1% SDS
at 37°C for 30 min. The liberated double-stranded RNA
(dsRNA) was isolated by phenol–chloroform extraction
and ethanol precipitation and resuspended in TNE (10
mM tris, pH 7.5, 150 mM NaCl, 1 mM EDTA). The resus-
pended dsRNA was mixed with Laemmli’s electrophore-
sis sample buffer, heated to 65°C for 5 min, and fraction-
ated by SDS–PAGE (Laemmli, 1970) using 0.75-mm-thick,
20-cm-long 7% or 10% acrylamide gels to resolve various
size classes of the dsRNA. The gels were fixed and silver
stained according to the procedure of Blum et al. (1987).
Isolation of ARV reassortants
Reassortant viruses were isolated from QM5 cells
infected simultaneously with ARV-176 (m.o.i. of 5) and
ARV-138 (m.o.i. of 1), similar to previous reports (Ni and
Kemp, 1990, 1992). The progeny virions obtained from
coinfections were isolated by plaque assay, and individ-
ual plaques were picked and amplified by a single pas-
sage in QM5 cells. The RNA was isolated from pass 1
virus stocks and analyzed by SDS–PAGE. Virus reassor-
tants, containing various genome segments from both
parents, were plaque purified a second time and grown
to pass 2, and their RNA genome segment profiles were
rechecked by SDS–PAGE. One such reassortant, con-
taining nine genome segments from ARV-138 and the S1
genome segment from ARV-176, was used in this study to
determine the role of the S1 genome segment in syncy-
tium formation. A second reassortant containing the L2
and L3 genome segments of ARV-176 in an ARV-138
genetic background was used for comparison purposes.
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